These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 32758874)

  • 1. A novel clinical decision support system for liver fibrosis using evolutionary multi-objective method based numerical association analysis.
    Altay EV; Alatas B
    Med Hypotheses; 2020 Nov; 144():110028. PubMed ID: 32758874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association analysis of Parkinson disease with vocal change characteristics using multi-objective metaheuristic optimization.
    Altay EV; Alatas B
    Med Hypotheses; 2020 Aug; 141():109722. PubMed ID: 32305812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolutionary-driven support vector machines for determining the degree of liver fibrosis in chronic hepatitis C.
    Stoean R; Stoean C; Lupsor M; Stefanescu H; Badea R
    Artif Intell Med; 2011 Jan; 51(1):53-65. PubMed ID: 20675106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound Shear Wave Elastography for Liver Disease. A Critical Appraisal of the Many Actors on the Stage.
    Piscaglia F; Salvatore V; Mulazzani L; Cantisani V; Schiavone C
    Ultraschall Med; 2016 Feb; 37(1):1-5. PubMed ID: 26871407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic acid algorithm-based models for assessment of liver fibrosis: translation from basic science to clinical application.
    Babaei Z; Parsian H
    Hepatobiliary Pancreat Dis Int; 2016 Apr; 15(2):131-40. PubMed ID: 27020628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A stepwise algorithm using an at-a-glance first-line test for the non-invasive diagnosis of advanced liver fibrosis and cirrhosis.
    Boursier J; de Ledinghen V; Leroy V; Anty R; Francque S; Salmon D; Lannes A; Bertrais S; Oberti F; Fouchard-Hubert I; Calès P
    J Hepatol; 2017 Jun; 66(6):1158-1165. PubMed ID: 28088581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Enhanced liver fibrosis score is associated with clinical outcomes and disease progression in patients with chronic liver disease.
    Irvine KM; Wockner LF; Shanker M; Fagan KJ; Horsfall LU; Fletcher LM; Ungerer JP; Pretorius CJ; Miller GC; Clouston AD; Lampe G; Powell EE
    Liver Int; 2016 Mar; 36(3):370-7. PubMed ID: 26104018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New sequential combinations of non-invasive fibrosis tests provide an accurate diagnosis of advanced fibrosis in NAFLD.
    Boursier J; Guillaume M; Leroy V; Irlès M; Roux M; Lannes A; Foucher J; Zuberbuhler F; Delabaudière C; Barthelon J; Michalak S; Hiriart JB; Peron JM; Gerster T; Le Bail B; Riou J; Hunault G; Merrouche W; Oberti F; Pelade L; Fouchard I; Bureau C; Calès P; de Ledinghen V
    J Hepatol; 2019 Aug; 71(2):389-396. PubMed ID: 31102719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolutionary strategy to develop learning-based decision systems. Application to breast cancer and liver fibrosis stadialization.
    Gorunescu F; Belciug S
    J Biomed Inform; 2014 Jun; 49():112-8. PubMed ID: 24518558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?
    Sebastiani G; Alberti A
    J Viral Hepat; 2012 Jan; 19 Suppl 1():18-32. PubMed ID: 22233410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation.
    Crossan C; Tsochatzis EA; Longworth L; Gurusamy K; Davidson B; Rodríguez-Perálvarez M; Mantzoukis K; O'Brien J; Thalassinos E; Papastergiou V; Burroughs A
    Health Technol Assess; 2015 Jan; 19(9):1-409, v-vi. PubMed ID: 25633908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current strategies for quantitating fibrosis in liver biopsy.
    Wang Y; Hou JL
    Chin Med J (Engl); 2015 Jan; 128(2):252-8. PubMed ID: 25591571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SM-RuleMiner: Spider monkey based rule miner using novel fitness function for diabetes classification.
    Cheruku R; Edla DR; Kuppili V
    Comput Biol Med; 2017 Feb; 81():79-92. PubMed ID: 28027460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Justified granulation aided noninvasive liver fibrosis classification system.
    Bernas M; Orczyk T; Musialik J; Hartleb M; Błońska-Fajfrowska B
    BMC Med Inform Decis Mak; 2015 Aug; 15():64. PubMed ID: 26245999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of liver fibrosis.
    Adams LA
    J Gastroenterol Hepatol; 2011 May; 26(5):802-9. PubMed ID: 21198831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-objective evolutionary algorithms for fuzzy classification in survival prediction.
    Jiménez F; Sánchez G; Juárez JM
    Artif Intell Med; 2014 Mar; 60(3):197-219. PubMed ID: 24525210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update.
    Shiha G; Ibrahim A; Helmy A; Sarin SK; Omata M; Kumar A; Bernstien D; Maruyama H; Saraswat V; Chawla Y; Hamid S; Abbas Z; Bedossa P; Sakhuja P; Elmahatab M; Lim SG; Lesmana L; Sollano J; Jia JD; Abbas B; Omar A; Sharma B; Payawal D; Abdallah A; Serwah A; Hamed A; Elsayed A; AbdelMaqsod A; Hassanein T; Ihab A; GHaziuan H; Zein N; Kumar M
    Hepatol Int; 2017 Jan; 11(1):1-30. PubMed ID: 27714681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIH Consensus Statement on Management of Hepatitis C: 2002.
    NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Swarm Optimization approach for clinical knowledge mining.
    Christopher JJ; Nehemiah HK; Kannan A
    Comput Methods Programs Biomed; 2015 Oct; 121(3):137-48. PubMed ID: 26115604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Machine learning to support diagnostics in the domain of asymptomatic liver disease.
    Babic A; Bodemar G; Mathiesen U; Ahlfeldt H; Franzen L; Wigertz O
    Medinfo; 1995; 8 Pt 1():809-13. PubMed ID: 8591335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.